Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical decision-making on cerebral cavernous malformations.

H S Chang1, K Hongo, H Nakagawa

  • 1Department of Neurological Surgery, Aichi Medical University, Aichi, Japan. chang@achi med-u.ac.jp

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|September 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·1992
Same author

Prognostic factors in patients surviving for more than 1 or 5 years after removal of metastatic brain tumors.

Neurologia medico-chirurgica·1992
Same author

[The analysis of nuclear organizer regions of astrocytomas with various histologic malignancies].

No to shinkei = Brain and nerve·1992
Same author

Circadian variation of [3H]dopamine handling in adrenal chromaffin cells of mice.

Neuroscience letters·1992
Same author

Inactivation of substance P by granulation tissue-derived gelatinase.

Biochemical pharmacology·1992
Same author

Inhibition of nicotinic acetylcholine receptor-mediated secretion and synthesis of catecholamines by sea urchin toxin in cultured bovine adrenal medullary cells.

Biochemical pharmacology·1992

Surgical decisions for cerebral cavernous malformations depend on lesion location. Surgery offers minimal gain for superficial lesions but may benefit younger patients with deep lesions.

Area of Science:

  • Neurosurgery
  • Medical modeling

Background:

  • Cerebral cavernous malformations (CCMs) present a complex challenge for surgical decision-making.
  • Existing literature provides data for analyzing CCM treatment outcomes.

Purpose of the Study:

  • To clarify surgical decision-making for cerebral cavernous malformations.
  • To quantify the risks and benefits of surgery versus natural course for CCMs.

Main Methods:

  • Utilized a mathematical model to calculate morbidity-free survival curves for CCM patients.
  • Calculated morbidity-free life expectancies for patients undergoing surgery versus natural course.
  • Analyzed data based on lesion location (superficial vs. deep) and patient age.

Main Results:

Related Experiment Videos

  • For superficial CCMs, permissible surgical risks are low (0.4-2.8%), with minimal gain in life expectancy (0.0-1.1 years).
  • For deep CCMs, surgical risks are higher, especially in younger patients (64.1% for a 20-year-old).
  • Morbidity-free life expectancy gains are substantial for younger patients with deep CCMs (17-25 years for 20-year-olds), decreasing with age.

    • Conclusions:

    • Surgery appears justified for younger patients with deep cerebral cavernous malformations.
    • Surgery for superficial CCMs has limited indication based on bleeding risk.
    • Age and lesion location are critical factors in the risk-benefit analysis of CCM treatment.